{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:11:54Z","timestamp":1793686314975,"version":"4.5.1"},"reference-count":129,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Systemic sclerosis (SSc) is a heterogeneous autoimmune connective tissue disease characterized by immune dysregulation, microvascular dysfunction, and progressive fibrosis. It frequently involves the cardiopulmonary system, resulting in many different and serious complications. Cardiovascular manifestations include heart failure, myocarditis, pericardial disease, arrhythmias, coronary artery disease, and treatment-related toxicities such as hydroxychloroquine-induced cardiomyopathy. Pulmonary complications, particularly interstitial lung disease and pulmonary arterial hypertension, remain the leading causes of morbidity and mortality in SSc. Diagnosis relies on multidisciplinary and multimodal evaluation, including serologic testing, advanced imaging, and hemodynamic assessment. Management strategies are disease-specific and include guideline-directed medical therapy, immunosuppression, antifibrotic agents, and targeted pulmonary vasodilator therapy. This review provides a clinically focused overview of the major cardiopulmonary manifestations of SSc, with emphasis on diagnosis, management, and emerging therapeutic considerations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/crd.0000000000001399","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:00:12Z","timestamp":1784264412000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Cardiopulmonary Manifestations of Systemic Sclerosis: Pathophysiology, Clinical Presentation, and Management"],"prefix":"10.1097","author":[{"given":"Rimsha","family":"Ahmad","sequence":"first","affiliation":[{"name":"Department of Medicine, Westchester Medical Center, Valhalla, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhi","family":"Ramchandani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cardiology Division, Westchester Medical Center, Valhalla, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cardiology Division, Westchester Medical Center, Valhalla, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Cheikhali","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cardiology Division, Westchester Medical Center, Valhalla, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amha","family":"Weldehana","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center, Valhalla, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sienna","family":"Goren","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center, Valhalla, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Jhang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center, Valhalla, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna Margret","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center, Valhalla, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Saribekyan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center, Valhalla, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center, Valhalla, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cardiology Division, Westchester Medical Center, Valhalla, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg M.","family":"Lanier","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cardiology Division, Westchester Medical Center, Valhalla, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"R1-20260801","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis.","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260801","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R3-20260801","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e32834ff2e8","article-title":"Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers.","volume":"24","author":"Barnes","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"R4-20260801","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3899\/jrheum.2025-0610","article-title":"Prognostic and functional trajectories in idiopathic pulmonary fibrosis and systemic autoimmune rheumatic disease\u2013associated interstitial lung disease: insights from an Italian multicenter cohort.","volume":"53","author":"Fornaro","year":"2026","journal-title":"J Rheumatol"},{"key":"R5-20260801","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.chest.2018.05.002","article-title":"Long-term outcomes in systemic sclerosis-associated pulmonary arterial hypertension from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS).","volume":"154","author":"Kolstad","year":"2018","journal-title":"Chest"},{"key":"R6-20260801","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","article-title":"Long-term outcomes of scleroderma renal crisis.","volume":"133","author":"Steen","year":"2000","journal-title":"Ann Intern Med"},{"key":"R7-20260801","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1097\/CM9.0000000000000535","article-title":"Cardiac complications in systemic sclerosis: early diagnosis and treatment.","volume":"132","author":"Nie","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"R8-20260801","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/rheumatology\/ket377","article-title":"Cardiac arrhythmias and conduction defects in systemic sclerosis.","volume":"53","author":"Vacca","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"R9-20260801","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0021-9681(78)90092-9","article-title":"The epidemiology of systemic sclerosis (scleroderma) among male US veterans.","volume":"31","author":"Medsger","year":"1978","journal-title":"J Chronic Dis"},{"key":"R10-20260801","doi-asserted-by":"crossref","first-page":"101849","DOI":"10.1016\/j.berh.2023.101849","article-title":"Nailfold capillaroscopy.","volume":"37","author":"Smith","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R11-20260801","article-title":"Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry.","volume":"65","author":"De Angelis","year":"2026","journal-title":"Rheumatology (Oxford)"},{"key":"R12-20260801","doi-asserted-by":"crossref","first-page":"1691988","DOI":"10.3389\/fimmu.2025.1691988","article-title":"The clinical utility of autoantibodies in systemic sclerosis: a review with a focus on cohort differences and standardization.","volume":"16","author":"Komura","year":"2025","journal-title":"Front Immunol"},{"key":"R13-20260801","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/rheumatology\/kes315","article-title":"Systemic sclerosis without antinuclear antibodies or Raynaud\u2019s phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database.","volume":"52","author":"Schneeberger","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"R14-20260801","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12016-022-08946-w","article-title":"Systemic sclerosis-specific antibodies: novel and classical biomarkers.","volume":"64","author":"Cavazzana","year":"2023","journal-title":"Clin Rev AllergImmunol"},{"key":"R15-20260801","first-page":"S127","article-title":"Prevalence and clinical profiles of \u2018autoantibody-negative\u2019systemic sclerosis subjects.","volume":"32","author":"Hudson","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"R16-20260801","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative.","volume":"72","author":"Van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R17-20260801","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1749-6632.2009.04808.x","article-title":"The role of infections in the immunopathogenesis of systemic sclerosis: evidence from serological studies.","volume":"1173","author":"Arnson","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"R18-20260801","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.3390\/biomedicines10112765","article-title":"Profibrotic effects of endothelin-1 on fibroblasts mediated by aldosterone.","volume":"10","author":"Argentino","year":"2022","journal-title":"Biomedicines"},{"key":"R19-20260801","first-page":"835948","article-title":"Role of endothelial-to-mesenchymal transition in systemic sclerosis.","author":"Jimenez","year":"2013","journal-title":"Int Schol Res Notices"},{"key":"R20-20260801","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.autrev.2010.09.016","article-title":"Fibrosis and immune dysregulation in systemic sclerosis.","volume":"10","author":"Chizzolini","year":"2011","journal-title":"Autoimmun Rev"},{"key":"R21-20260801","doi-asserted-by":"crossref","first-page":"999008","DOI":"10.3389\/fimmu.2022.999008","article-title":"Dysregulated B-cell function in systemic sclerosis.","volume":"13","author":"Beesley","year":"2023","journal-title":"Front Immunol"},{"key":"R22-20260801","doi-asserted-by":"crossref","first-page":"933468","DOI":"10.3389\/fimmu.2022.933468","article-title":"Role of B cells in systemic sclerosis.","volume":"13","author":"Thoreau","year":"2022","journal-title":"Front Immunol"},{"key":"R23-20260801","doi-asserted-by":"crossref","first-page":"14287","DOI":"10.3390\/ijms241814287","article-title":"The pathogenesis of systemic sclerosis.","volume":"24","author":"Ko","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R24-20260801","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/IBPC.S232038","article-title":"Management of pulmonary arterial hypertension in systemic sclerosis.","volume":"13","author":"Almaaitah","year":"2020","journal-title":"Integr Blood Press Control"},{"key":"R25-20260801","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","article-title":"Systemic sclerosis: demographic and clinical features.","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine (Baltim)"},{"key":"R26-20260801","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/rheumatology\/ker357","article-title":"Cardiopulmonary manifestations and mortality in SSc.","volume":"51","author":"Kom\u00f3csi","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R27-20260801","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4330\/wjc.v6.i9.993","article-title":"Cardiac manifestations in systemic sclerosis.","volume":"6","author":"Lambova","year":"2014","journal-title":"World J Cardiol"},{"key":"R28-20260801","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.rdc.2007.12.002","article-title":"The heart in scleroderma.","volume":"34","author":"Champion","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"R29-20260801","doi-asserted-by":"crossref","first-page":"e0126707","DOI":"10.1371\/journal.pone.0126707","article-title":"Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy.","volume":"10","author":"Mueller","year":"2015","journal-title":"PLoS One"},{"key":"R31-20260801","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5114\/reum.2019.87619","article-title":"Systemic sclerosis\u2014multidisciplinary disease.","volume":"57","author":"Sobolewski","year":"2019","journal-title":"Reumatologia"},{"key":"R32-20260801","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association.","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"key":"R33-20260801","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.jacc.2023.09.819","article-title":"Novel imaging approaches to cardiac manifestations of systemic inflammatory diseases: JACC scientific statement.","volume":"82","author":"Weber","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R34-20260801","first-page":"1941","article-title":"High prevalence of right ventricular dysfunction in early SSc.","volume":"31","author":"Meune","year":"2004","journal-title":"J Rheumatol"},{"key":"R35-20260801","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jacc.2018.07.068","article-title":"Left ventricular diastolic dysfunction predicts mortality in SSc.","volume":"72","author":"Tenn\u00f8e","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R36-20260801","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keag064","article-title":"Cardiac involvement in systemic sclerosis: mechanisms, manifestations and management.","volume":"65","author":"Soo","year":"2026","journal-title":"Rheumatology (Oxford)"},{"key":"R37-20260801","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis.","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"R38-20260801","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2023.12.024","article-title":"2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee.","volume":"83","author":"Maddox","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"R39-20260801","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","article-title":"Systemic sclerosis\u2013associated interstitial lung disease.","volume":"8","author":"Perelas","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R40-20260801","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41584-023-00909-5","article-title":"State-of-the-art evidence in the treatment of systemic sclerosis.","volume":"19","author":"Pope","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"R41-20260801","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s10787-021-00887-8","article-title":"Effects of hydroxychloroquine and its metabolites.","volume":"29","author":"Eryavuz Onmaz","year":"2021","journal-title":"Inflammopharmacol"},{"key":"R42-20260801","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/10600280231204969","article-title":"Hydroxychloroquine and QT prolongation.","volume":"58","author":"Garcia","year":"2024","journal-title":"Ann Pharmacother"},{"key":"R43-20260801","first-page":"1706","article-title":"Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment.","volume":"30","author":"Yogasundaram","year":"2014","journal-title":"Can J Cardiol"},{"key":"R44-20260801","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/ajcp\/aqaa253","article-title":"Chloroquine- and hydroxychloroquine-induced cardiomyopathy: a case report and brief literature review.","volume":"155","author":"Nadeem","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"R45-20260801","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","article-title":"Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature.","volume":"41","author":"Chatre","year":"2018","journal-title":"Drug Saf"},{"key":"R46-20260801","first-page":"e251315","article-title":"Hydroxychloroquine cardiomyopathy\u2014a case series and review of the literature.","volume":"5","author":"Huhulea","year":"2026","journal-title":"Ann Int Med"},{"key":"R47-20260801","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00296-024-05699-x","article-title":"Heart involvement in systemic sclerosis.","volume":"44","author":"Nadel","year":"2024","journal-title":"Rheumatol Int"},{"key":"R48-20260801","first-page":"2523","article-title":"Systemic sclerosis myocarditis.","volume":"59","author":"Luca","year":"2020","journal-title":"Rheumatology"},{"key":"R49-20260801","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2024.10.080","article-title":"2024 ACC expert consensus decision pathway on strategies and criteria for the diagnosis and management of myocarditis: a report of the American College of Cardiology Solution Set Oversight Committee.","volume":"85","author":"Drazner","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"R50-20260801","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1093\/rheumatology\/keac098","article-title":"Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation.","volume":"61","author":"Luca","year":"2022","journal-title":"Rheumatology"},{"key":"R51-20260801","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/rheumatology\/keac504","article-title":"Cardiac magnetic resonance imaging before and after therapeutic interventions for systemic sclerosis-associated myocarditis.","volume":"62","author":"Panopoulos","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"R52-20260801","doi-asserted-by":"crossref","first-page":"1614714","DOI":"10.3389\/fimmu.2025.1614714","article-title":"Tocilizumab combined with cyclophosphamide for the treatment of rapidly progressive refractory systemic sclerosis with predominant cardiac involvement: a case report.","volume":"16","author":"Fu","year":"2025","journal-title":"Front Immunol"},{"key":"R53-20260801","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.semarthrit.2013.07.006","article-title":"Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression.","volume":"43","author":"Pieroni","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"R54-20260801","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s41927-023-00360-9","article-title":"Pericardialeffusions andcardiac tamponade in hospitalized systemic sclerosis patients: analysis of the national inpatient sample.","volume":"7","year":"2023","journal-title":"BMC Rheumatol"},{"key":"R55-20260801","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3949\/ccjm.86a.18109","article-title":"Cardiovascular complications of systemic sclerosis.","volume":"86","author":"Mani","year":"2019","journal-title":"Cleve Clin J Med"},{"key":"R56-20260801","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1378\/chest.06-2317","article-title":"Pericardial abnormalities predict PAH in SSc-ILD.","volume":"131","author":"Fischer","year":"2007","journal-title":"Chest"},{"key":"R57-20260801","doi-asserted-by":"crossref","first-page":"17","DOI":"10.15420\/aer.2020.43","article-title":"Arrhythmias and conduction disturbances in autoimmune rheumatic disorders.","volume":"10","author":"Plastiras","year":"2021","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"Suppl 4","key":"R58-20260801","doi-asserted-by":"crossref","first-page":"iv39","DOI":"10.1093\/rheumatology\/kel315","article-title":"Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases.","volume":"45","author":"Seferovi\u0107","year":"2006","journal-title":"Rheumatology"},{"key":"R59-20260801","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euac053.124","article-title":"Incidence and predictors of cardiac arrhythmias in patients with systemic sclerosis.","volume":"24","author":"Stronati","year":"2022","journal-title":"Europace"},{"key":"R60-20260801","doi-asserted-by":"crossref","first-page":"12963","DOI":"10.3390\/ijms232112963","article-title":"Arrhythmias and conduction disturbances in patients with systemic sclerosis: a systematic literature review.","volume":"23","author":"Vrancianu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R61-20260801","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/RHU.0000000000000623","article-title":"Relationship between ventricular arrhythmias and myocardial fibrosis in systemic sclerosis.","volume":"24","author":"Muresan","year":"2018","journal-title":"J Clin Rheumatol"},{"key":"R62-20260801","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5114\/ada.2021.106203","article-title":"Sinoatrial conduction abnormalities: an underestimated cardiac complication in women with systemic sclerosis.","volume":"38","author":"Kramarz","year":"2021","journal-title":"Adv Dermatol Allergol"},{"key":"R63-20260801","doi-asserted-by":"crossref","first-page":"e013405","DOI":"10.1161\/JAHA.119.013405","article-title":"Cardiovascular manifestations of systemic sclerosis: a Danish nationwide cohort study.","volume":"8","author":"Butt","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"R64-20260801","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1097\/RHU.0000000000001638","article-title":"Heart valve abnormalities in systemic sclerosis patients.","volume":"28","author":"Colaci","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"R65-20260801","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3899\/jrheum.201005","article-title":"Increased risk of valvular heart disease in systemic sclerosis.","volume":"48","author":"Kurmann","year":"2021","journal-title":"J Rheumatol"},{"key":"R66-20260801","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"77","author":"Otto","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R67-20260801","doi-asserted-by":"crossref","first-page":"849086","DOI":"10.3389\/fmed.2022.849086","article-title":"Endothelial dysfunction in systemic lupus erythematosus and systemic sclerosis.","volume":"9","author":"Moschetti","year":"2022","journal-title":"Front Med"},{"key":"R68-20260801","doi-asserted-by":"crossref","first-page":"iv14","DOI":"10.1093\/rheumatology\/kel312","article-title":"Primary myocardial involvement in systemic sclerosis.","volume":"45","author":"Kahan","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R69-20260801","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.53.3.483","article-title":"Myocardial lesions of progressive systemic sclerosis.","volume":"53","author":"Bulkley","year":"1976","journal-title":"Circulation"},{"key":"R70-20260801","doi-asserted-by":"crossref","first-page":"e33442","DOI":"10.1371\/journal.pone.0033442","article-title":"Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases.","volume":"7","author":"Z\u00f6ller","year":"2012","journal-title":"PLoS One"},{"key":"R71-20260801","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.amjmed.2013.06.025","article-title":"Increased risk of acute myocardial infarction in systemic sclerosis.","volume":"126","author":"Chu","year":"2013","journal-title":"Am J Med"},{"key":"R72-20260801","doi-asserted-by":"crossref","first-page":"16","DOI":"10.31083\/j.fbs1504016","article-title":"Systemic sclerosis and atherosclerosis.","volume":"15","author":"Gerasimova","year":"2023","journal-title":"Front Biosc (Schol Ed)"},{"key":"R73-20260801","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1136\/annrheumdis-2013-203535","article-title":"Vascular endothelial growth factor aggravates fibrosis in systemic sclerosis.","volume":"73","author":"Maurer","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R74-20260801","doi-asserted-by":"crossref","first-page":"152126","DOI":"10.1016\/j.semarthrit.2022.152126","article-title":"Cardiac inflammation and fibrosis patterns in systemic sclerosis.","volume":"58","author":"Mavrogeni","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"R75-20260801","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/rheumatology\/kew224","article-title":"BSR and BHPR guideline for the treatment of systemic sclerosis.","volume":"55","author":"Denton","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R76-20260801","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kep105","article-title":"Digital ulcers in systemic sclerosis.","volume":"48","author":"Steen","year":"2006","journal-title":"Rheumatology"},{"key":"R77-20260801","doi-asserted-by":"crossref","first-page":"923743","DOI":"10.1155\/2010\/923743","article-title":"Digital ischemia in scleroderma.","volume":"2010","author":"Schiopu","year":"2010","journal-title":"Int J Rheumatol"},{"key":"R78-20260801","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis.","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R79-20260801","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-023-06796-1","article-title":"Effect of calcium channel blockers on digital ulcers.","volume":"43","author":"Ross","year":"2024","journal-title":"Clin Rheumatol"},{"key":"R80-20260801","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamadermatol.2021.1463","article-title":"A practical approach to the management of digital ulcers in patients with systemic sclerosis: a narrative review.","volume":"157","author":"Hughes","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R81-20260801","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2017.11.020","article-title":"Scleroderma skin ulcers definition, classification and treatment strategies: our experience and review of the literature.","volume":"17","author":"Giuggioli","year":"2018","journal-title":"Autoimmun Rev"},{"key":"R82-20260801","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/annrheumdis-2014-207001","article-title":"Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study.","volume":"75","author":"Hachulla","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R83-20260801","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(06)68737-0","article-title":"Systemic sclerosis: hypothesis-driven treatment strategies.","volume":"367","author":"Charles","year":"2006","journal-title":"Lancet"},{"key":"R84-20260801","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.2010.130658","article-title":"Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.","volume":"70","author":"Matucci-Cerinic","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R85-20260801","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1093\/rheumatology\/keaf292","article-title":"Long-term effects of selexipag in SSc-associated digital ulcers: a case-control multicentre observational study.","volume":"64","author":"Iannone","year":"2025","journal-title":"Rheumatology"},{"key":"R86-20260801","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamadermatol.2025.4929","article-title":"Botulinum toxin for refractory digital ischemia and ulcers in systemic sclerosis: a systematic review and meta-analysis.","volume":"162","author":"Zhu","year":"2026","journal-title":"JAMA Dermatol"},{"key":"R87-20260801","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1038\/s41598-024-57275-9","article-title":"Association between systemic sclerosis and risk of cerebrovascular disease.","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"R88-20260801","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13075-014-0435-y","article-title":"Risk of venous thromboembolism in inflammatory rheumatic diseases.","volume":"16","author":"Lee","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R89-20260801","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1164\/rccm.202306-1113ST","article-title":"Treatment of systemic sclerosis-associated interstitial lung disease: evidence-based recommendations.","volume":"209","author":"Raghu","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R90-20260801","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1164\/rccm.201903-0563CI","article-title":"Etiology and risk factors in systemic sclerosis with ILD.","volume":"201","author":"Khanna","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R91-20260801","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12931-019-0980-7","article-title":"Interstitial lung disease associated with systemic sclerosis (SSc-ILD).","volume":"20","author":"Cottin","year":"2019","journal-title":"Respir Res"},{"key":"R92-20260801","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12931-022-02292-3","article-title":"Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.","volume":"24","author":"Rahaghi","year":"2023","journal-title":"Respir Res"},{"key":"R93-20260801","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11926-022-01067-5","article-title":"Detection and monitoring of interstitial lung disease in patients with systemic sclerosis.","volume":"24","author":"Khanna","year":"2022","journal-title":"Curr Rheumatol Rep"},{"key":"R94-20260801","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/rheumatology\/keae110","article-title":"Serum biomarkers associated with mortality in systemic sclerosis.","volume":"63","author":"Parker","year":"2024","journal-title":"Rheumatology"},{"key":"R95-20260801","article-title":"Phase 3 trials of inhaled treprostinil for idiopathic pulmonary fibrosis [published online ahead of print May 18, 2026].","author":"Nathan","journal-title":"N Engl J Med."},{"key":"R96-20260801","doi-asserted-by":"crossref","first-page":"152959","DOI":"10.1016\/j.semarthrit.2026.152959","article-title":"Trends and outcomes of lung transplant listings for connective tissue disease-associated interstitial lung disease (CTD-ILD): a 20-year analysis from the organ procurement and transplantation network database.","volume":"78","author":"Bhandari","year":"2026","journal-title":"Semin Arthritis Rheum"},{"key":"R97-20260801","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.rmed.2013.09.015","article-title":"Survival after lung transplantation in systemic sclerosis.","volume":"107","author":"Khan","year":"2013","journal-title":"Respir Med"},{"key":"R98-20260801","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keag200","article-title":"Lung transplant outcomes in myositis, systemic sclerosis and idiopathic pulmonary fibrosis: a multicenter retrospective analysis.","volume":"65","author":"Chang","year":"2026","journal-title":"Rheumatology (Oxford)"},{"key":"R99-20260801","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1365-2982.2010.01522.x","article-title":"Gastroesophageal reflux and altered motility in lung transplant rejection.","volume":"22","author":"Castor","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"R100-20260801","doi-asserted-by":"crossref","first-page":"908693","DOI":"10.3389\/fimmu.2022.908693","article-title":"Lymphocytic airway inflammation in lung allografts.","volume":"13","author":"Santos","year":"2022","journal-title":"Front Immunol"},{"key":"R101-20260801","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5858\/arpa.2016-0459-SA","article-title":"Diagnosis of acute cellular rejection and antibody-mediated rejection on lung transplant biopsies: a perspective from members of the pulmonary pathology society.","volume":"141","author":"Roden","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"R102-20260801","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/acr.25133","article-title":"Lung transplantation: a viable option for connective tissue disease?","volume":"75","author":"Zhang","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R103-20260801","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11926-017-0650-z","article-title":"Lung transplantation in patients with systemic sclerosis.","volume":"19","author":"Shah","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"R105-20260801","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00464-024-11392-8","article-title":"Interventional anti-reflux management for gastro-oesophageal reflux disease in lung transplant recipients: a systematic review and meta-analysis.","volume":"39","author":"Krahelski","year":"2025","journal-title":"Surg Endosc"},{"key":"R106-20260801","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1007\/s00464-023-10245-0","article-title":"Laparoscopic Toupet fundoplication: a safe and effective anti-reflux option in lung transplant recipients.","volume":"37","author":"Yergin","year":"2023","journal-title":"Surg Endosc"},{"key":"R107-20260801","first-page":"870","article-title":"Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients.","volume":"88","author":"Yarze","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"R108-20260801","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox067","article-title":"Spectrum of esophageal dysmotility in systemic sclerosis on high-resolution esophageal manometry as defined by Chicago classification.","volume":"30","author":"Aggarwal","year":"2017","journal-title":"Dis Esophagus"},{"key":"R109-20260801","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1164\/rccm.200808-1359OC","article-title":"Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring.","volume":"179","author":"Savarino","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R110-20260801","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.semarthrit.2006.08.002","article-title":"Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.","volume":"36","author":"Ntoumazios","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"R111-20260801","doi-asserted-by":"crossref","first-page":"103506","DOI":"10.1016\/j.autrev.2023.103506","article-title":"Pulmonary arterial hypertension associated with connective tissue disease.","volume":"23","author":"Thoreau","year":"2024","journal-title":"Autoimmun Rev"},{"key":"R112-20260801","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3899\/jrheum.100245","article-title":"Prevalence of pulmonary hypertension in systemic sclerosis.","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"key":"R113-20260801","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis.","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R114-20260801","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in connective tissue disease-associated PAH.","volume":"58","author":"Jais","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R115-20260801","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.3390\/ijms21124430","article-title":"Pulmonary hypertension phenotypes in systemic sclerosis.","volume":"21","author":"Attanasio","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R116-20260801","doi-asserted-by":"crossref","first-page":"210053","DOI":"10.1183\/16000617.0053-2021","article-title":"Pulmonary hypertension phenotypes in systemic sclerosis.","volume":"30","author":"Haque","year":"2021","journal-title":"Eur Respir Rev"},{"key":"R117-20260801","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension.","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"key":"R118-20260801","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension.","volume":"62","author":"Hoeper","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R119-20260801","first-page":"458","article-title":"Assessment of pulmonary arterial hypertension in systemic sclerosis.","volume":"35","author":"Hsu","year":"2008","journal-title":"J Rheumatol"},{"key":"R120-20260801","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/annrheumdis-2019-216274","article-title":"Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis.","volume":"79","author":"Kuwana","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R122-20260801","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension.","volume":"388","author":"Hoeper","year":"2023","journal-title":"N Engl J Med"},{"key":"R123-20260801","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa2415160","article-title":"Sotatercept in patients with pulmonary arterial hypertension at high risk for death.","volume":"392","author":"Humbert","year":"2025","journal-title":"N Engl J Med"},{"key":"R124-20260801","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa2508170","article-title":"Sotatercept for pulmonary arterial hypertension within the first year after diagnosis.","volume":"393","author":"McLaughlin","year":"2025","journal-title":"N Engl J Med"},{"key":"R125-20260801","doi-asserted-by":"crossref","first-page":"e12276","DOI":"10.1002\/pul2.12276","article-title":"Connective tissue disease-associated pulmonary hypertension.","volume":"13","author":"Khangoora","year":"2023","journal-title":"Pulm Circ"},{"key":"R126-20260801","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMra2000348","article-title":"Pulmonary arterial hypertension.","volume":"385","author":"Hassoun","year":"2021","journal-title":"N Engl J Med"},{"key":"R127-20260801","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/rheumatology\/kead360","article-title":"Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.","volume":"63","author":"Distler","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R128-20260801","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1164\/rccm.202204-0731OC","article-title":"Improved survival for patients with systemic sclerosis-associated pulmonary arterial hypertension: the Johns Hopkins Registry.","volume":"207","author":"Hassan","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"R129-20260801","first-page":"957","article-title":"Examining the case for palliative care in systemic sclerosis.","volume":"51","author":"McDonald","year":"2024","journal-title":"J Rheumatol"},{"key":"R130-20260801","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/acr.25325","article-title":"Quantifying the need for specialist palliative care in systemic sclerosis.","volume":"76","author":"Ross","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R131-20260801","article-title":"Patient and caregiver perspectives of an integrated scleroderma and palliative care service.","author":"Wicks","year":"2024","journal-title":"BMJ Support Palliat Care"},{"key":"R132-20260801","first-page":"D8025","article-title":"Palliative care in practice.","volume":"168","author":"Wilczkowski","year":"2024","journal-title":"Palliat Pract"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000001399","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T08:00:24Z","timestamp":1785571224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000001399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":129,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001399","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}